A team of pharmacists and chemists from the National University of Singapore (NUS) has developed a new anti-cancer drug that has less toxic effects to the kidneys. The new drug works like a "magic bullet" that is delivered ...
Sep 18, 2019
0
5
Scientists have revealed close-up details of a vital molecule involved in the mix and match of genetic information within cells—opening up the potential to target proteins of this family to combat cancer's diversity and ...
Sep 14, 2019
0
60
Scientists at Sanford Burnham Prebys have identified the long-sought structure of an essential blood protein: vitronectin. Knowing the protein's structure—an advance that enables rational drug design—could lead to medicines ...
Sep 12, 2019
0
142
Many patients see their tumors shrink in response to a drug, only to have them come back with a vengeance as they evolve to fend off the treatment. Oncologists want to be able to quickly detect cancer drug resistance as it ...
Sep 9, 2019
0
54
Scientists from the National Institutes of Health and Cincinnati Children's Hospital Medical Center have devised a potential treatment against a common type of leukemia that could have implications for many other types of ...
Sep 4, 2019
0
156
Although the number of women being diagnosed and dying of ovarian cancer is declining, recurrence, drug resistance and mortality remain high for women with high-grade serous ovarian carcinoma, the most common form of epithelial ...
Sep 4, 2019
0
60
Cancer treatments can work in lots of different ways, aiming to kill tumor cells or keep them under control. Ideally they cause tumors to shrink, but drugs can also be considered successful if they stop tumors growing.
Aug 30, 2019
0
1
Prostate cancer, the second leading cause of cancer-related death for men in the United States, is poorly responsive to immunotherapy. Recent clinical trials have hinted that combining immunotherapy and radiation therapy ...
Aug 26, 2019
0
2
Every year, more than 250,000 women in the U.S. are diagnosed with breast cancer. When detected early, patients with the most common form—which tests positive for hormone receptors (HR+) and negative for the HER2 receptor—usually ...
Aug 22, 2019
0
15
Epithelial cancers, such as cancers of the lung and pancreas, use the ανβ3 molecule to gain drug resistance to standard cancer therapies and to become highly metastatic. In a paper published in Cancer Research, University ...
Aug 21, 2019
0
7
